38th week of 2017 patent applcation highlights part 8 |
Patent application number | Title | Published |
20170266071 | FITTING SYSTEM AND METHOD FOR MODULAR PRESSURE RELIEF CUSHION | 2017-09-21 |
20170266072 | PATIENT MANEUVERING APPARATUS | 2017-09-21 |
20170266073 | LEG ASSEMBLY FOR A MASSAGE TABLE | 2017-09-21 |
20170266074 | GARMENT SYSTEM INCLUDING AT LEAST ONE MUSCLE OR JOINT ACTIVITY SENSOR AND AT LEAST ONE ACTUATOR RESPONSIVE TO THE SENSOR AND RELATED METHODS | 2017-09-21 |
20170266075 | Aid device for the movement and/or rehabilitation of one or more fingers of a hand | 2017-09-21 |
20170266076 | Massage Device | 2017-09-21 |
20170266077 | ROBOTIC MASSAGE MACHINE AND METHOD OF USE | 2017-09-21 |
20170266078 | EXTERNAL CHEST COMPRESSION AND DEFIBRILLATION SYSTEMS, DEVICES AND METHODS OF OPERATION | 2017-09-21 |
20170266079 | HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS | 2017-09-21 |
20170266080 | PHARMACEUTICAL PRODUCT | 2017-09-21 |
20170266081 | RADICAL POLYMERISATION INITIATORS FOR LIGHT-CURABLE DENTAL MATERIALS | 2017-09-21 |
20170266082 | STICK-SHAPED COSMETIC FOR MOISTURE REPLENISHMENT | 2017-09-21 |
20170266083 | POLYURETHANE MICROPARTICLES COATED WITH A ZINC SALT AND METHODS FOR THE PREPARATION THEREOF | 2017-09-21 |
20170266084 | ZINC OXIDE WHICH IS COATED WITH SILICON OXIDE, METHOD FOR MANUFACTURING THE SAME, COMPOSITION WHICH INCLUDES THE ZINC OXIDE COATED WITH SILICON OXIDE, AND COSMETIC | 2017-09-21 |
20170266085 | CORE-SHELL TYPE POLYMER PARTICLE, AQUEOUS POLYMER EMULSION, AND HAIR COSMETIC COMPOSITION | 2017-09-21 |
20170266086 | OXIDIZING COLORANT | 2017-09-21 |
20170266087 | AQUEOUS OR AQUEOUS-ALCOHOLIC GEL OF SYNTHETIC PHYLLOSILICATES AS VISCOSITY-ENHANCING, MATT-EFFECT AND/OR APPLICATION-HOMOGENIZING AGENT | 2017-09-21 |
20170266088 | SKIN-WHITENING COSMETIC COMPOSITION CONTAINING ROSEMARY-DERIVED VERBENONE AS ACTIVE INGREDIENT | 2017-09-21 |
20170266089 | USE OF LIPOPHILIC SALICYLIC ACID DERIVATIVES | 2017-09-21 |
20170266090 | ANTIMICROBIAL COMPOSITIONS THAT ARE DERMATOLOGICALLY NON-DRYING | 2017-09-21 |
20170266091 | Mouthwash Composition Comprising a Peroxide Source and an N-Acyl-L-Arginine Alkyl Ester Salt | 2017-09-21 |
20170266092 | Tooth Whitening Oral Care Products | 2017-09-21 |
20170266093 | AGENTS FOR DYEING KERATIN FIBRES, CONTAINING AT LEAST ONE DIMERIC, DICATIONIC AZO DYE WITH SPECIAL SUBSTITUTION PATTERN | 2017-09-21 |
20170266094 | AGENTS FOR DYEING KERATIN FIBERS, CONTAINING AT LEAST ONE DIMERIC, DICATIONIC AZO DYE AND AT LEAST ONE ANIONIC AND/OR CATIONIC SURFACTANT | 2017-09-21 |
20170266095 | METHOD FOR EXTRACTING AND PRODUCING USEFUL SUBSTANCE, AND SOAP, COSMETICS, OR HEALTH SUPPLEMENT HAVING SAID USEFUL SUBSTANCE AS MAIN COMPONENT | 2017-09-21 |
20170266096 | PERSONAL CARE COMPOSITION FOR A KERATIN SUBSTRATE COMPRISING CONDITIONING AND/OR STYLING POLYMER | 2017-09-21 |
20170266097 | Method of Preparing Hair Conditioning Composition Comprising Mono-Alkyl Amine Cationic Surfactant and Anionic Polymer | 2017-09-21 |
20170266098 | AGENT AND METHOD FOR THE TEMPORARY SHAPING OF KERATIN-CONTAINING FIBERS | 2017-09-21 |
20170266099 | COMPOSITION COMPRISING CONDITIONING AND/OR STYLING POLYMER | 2017-09-21 |
20170266100 | AGENTS AND METHODS FOR THE TEMPORARY SHAPING OF KERATIN-CONTAINING FIBERS | 2017-09-21 |
20170266101 | KERATINOUS FIBER CARE PRODUCT AND METHOD | 2017-09-21 |
20170266102 | GEL POLISH COMPOSITION | 2017-09-21 |
20170266103 | MICROCAPSULES CONTAINING A GAS-GENERATING PHOTOLABILE POLYMER AND USES THEREOF | 2017-09-21 |
20170266104 | COMPOSITION FOR ALTERING THE COLOR OF KERATIN FIBERS | 2017-09-21 |
20170266105 | TOPICAL DEODORANT MADE WITH 100% VEGAN INGREDIENTS | 2017-09-21 |
20170266106 | METHODS AND COMPOSITIONS FOR TREATING MIGRAINE AND CONDITIONS ASSOCIATED WITH PAIN | 2017-09-21 |
20170266107 | TREATMENT FOR CHRONIC MYOCARDIAL INFARCT | 2017-09-21 |
20170266108 | INTRAVENOUS ADMINISTRATION OF TRAMADOL | 2017-09-21 |
20170266109 | RAPAMYCIN FORMULATIONS AND METHODS OF THEIR USE | 2017-09-21 |
20170266110 | DRUG DELIVERY SYSTEM AND METHOD OF TREATING OCULAR DISEASES IN ANIMALS | 2017-09-21 |
20170266111 | LOCAL ADMINISTRATION-TYPE PHARMACEUTICAL FOR IMPROVING DYSPHAGIA | 2017-09-21 |
20170266112 | RESIDENCE STRUCTURES AND RELATED METHODS | 2017-09-21 |
20170266113 | NEBULIZABLE COMPOSITIONS OF QUATERNARY AMMONIUM MUSCARINIC RECEPTOR ANTAGONISTS | 2017-09-21 |
20170266114 | LIPID VESICLE COMPOSITIONS AND METHODS OF USE | 2017-09-21 |
20170266115 | PALATABLE COMPOSITIONS INCLUDING SODIUM PHENYLBUTYRATE AND USES THEREOF | 2017-09-21 |
20170266116 | GASTRO-RETENTIVE SUSTAINED-RELEASE ORAL DOSAGE FORM OF A BILE ACID SEQUESTRANT | 2017-09-21 |
20170266117 | DELAYED RELEASE DRUG FORMULATION | 2017-09-21 |
20170266118 | ALL NATURAL, NON-TOXIC SUBLINGUAL DRUG DELIVERY SYSTEMS | 2017-09-21 |
20170266119 | HYPERBRANCHED POLYGLYCEROL-COATED PARTICLES AND METHODS OF MAKING AND USING THEREOF | 2017-09-21 |
20170266120 | NANOCRYSTALS, COMPOSITIONS, AND METHODS THAT AID PARTICLE TRANSPORT IN MUCUS | 2017-09-21 |
20170266121 | SUSTAINED-RELEASE FORMULATIONS OF TOPIRAMATE | 2017-09-21 |
20170266122 | METHOD OF MAKING PARTICLES FOR USE IN A PHARMACEUTICAL COMPOSITION | 2017-09-21 |
20170266123 | COATED PARTICLES FOR DRUG DELIVERY | 2017-09-21 |
20170266124 | Conjugated Polymer Nanoparticles and Manufacturing Method Thereof | 2017-09-21 |
20170266125 | Multiparticulate L-Menthol Formulations and Related Methods | 2017-09-21 |
20170266126 | Use of Cannabinoids in the Treatment of Epilepsy | 2017-09-21 |
20170266127 | CANNABINOID EMULSION PRODUCT AND PROCESS FOR MAKING THE SAME | 2017-09-21 |
20170266128 | TOPICAL REGIONAL NEURO-AFFECTIVE THERAPY IN MAMMALS WITH CANNABINOIDS | 2017-09-21 |
20170266129 | FOODS, SYSTEMS, METHODS, AND KITS FOR PROVIDING ELECTROLYTE REPLACEMENT | 2017-09-21 |
20170266130 | COMPOSITIONS, METHODS FOR MAKING THE COMPOSITIONS, AND METHODS FOR TREATING JOINT DISEASE | 2017-09-21 |
20170266131 | Modulation of Macrophage Phenotype by Emodin | 2017-09-21 |
20170266132 | METHOD FOR TREATING HYPERHIDROSIS | 2017-09-21 |
20170266133 | METHODS AND COMPOSITIONS OF DASOTRALINE FOR TREATMENT OF ADHD | 2017-09-21 |
20170266134 | DOSAGE OF DASOTRALINE AND METHOD FOR TREATMENT OF ADHD | 2017-09-21 |
20170266135 | PROCESS FOR PREPARING THE INHALATION FORMULATIONS | 2017-09-21 |
20170266136 | COMPOUNDS FOR THE TREATMENT OF MITOCHONDRIAL DISEASES | 2017-09-21 |
20170266137 | LIPOLYTIC METHODS | 2017-09-21 |
20170266138 | METHODS OF TREATMENT OF ACNE VULGARIS USING TOPICAL DAPSONE COMPOSITIONS | 2017-09-21 |
20170266139 | INJECTABLE RESINIFERATOXIN | 2017-09-21 |
20170266140 | Compositions for Modulating Cancer Stem Cells and Uses Therefor | 2017-09-21 |
20170266141 | METHODS AND MATERIALS FOR REDUCING ISCHEMIA-REPERFUSION INJURY | 2017-09-21 |
20170266142 | Method Of Treating Chronic Obstructive Pulmonary Disease (CPD) With Verproside | 2017-09-21 |
20170266143 | METHODS OF THERAPEUTIC MONITORING OF PHENYLACETIC ACID PRODRUGS | 2017-09-21 |
20170266144 | Compositions and Methods for Diagnosis and Treatment of Metabolic Syndrome | 2017-09-21 |
20170266145 | METHODS OF INDUCING METABOLIC MATURATION OF HUMAN PLURIPOTENT STEM CELLS-DERIVED HEPATOCYTES | 2017-09-21 |
20170266146 | COMPOSITIONS AND METHODS FOR TREATMENT OF RETINAL DEGENERATIVE DISEASES | 2017-09-21 |
20170266147 | METHODS OF INCREASING LATENCY OF ANESTHETIC INDUCTION USING KETONE SUPPLEMENTATION | 2017-09-21 |
20170266148 | COMPOSITIONS AND METHODS FOR PRODUCING ELEVATED AND SUSTAINED KETOSIS | 2017-09-21 |
20170266149 | SOLID FORMS OF SELECTIVE ANDROGEN RECEPTOR MODULATORS | 2017-09-21 |
20170266150 | USE OF SUBSTITUTED HEXITOLS INCLUDING DIANHYDROGALACTITOL AND ANALOGS TO TREAT NEOPLASTIC DISEASE AND CANCER STEM CELLS INCLUDING GLIOBLASTOMA MULTFORME AND MEDULLOBLASTOMA | 2017-09-21 |
20170266151 | Novel salts of 3-[(DIMETHYLAMINO)METHYL]-N--1-BENZOFURAN-2-CARBOXAMIDE, related crystalline forms, method for preparing the same and pharmaceutical compositions containing the same | 2017-09-21 |
20170266152 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF | 2017-09-21 |
20170266153 | COMPOSITIONS PURPOSEFULLY SELECTED COMPRISING PURIFIED CANNABINOIDS AND/OR PURIFIED TERPENES | 2017-09-21 |
20170266154 | METHOD FOR TREATING ALZHEIMER'S DISEASE AND 2, 3-BIPHOSPHOGLYCERATE METABOLISM DISORDER INDUCED | 2017-09-21 |
20170266155 | METHOD FOR ENHANCING THE OXYGENATION LEVEL OF TISSUE CELLS AS AN ALTERNATIVE METHOD FOR HYPERBARIC OXYGEN THERAPY | 2017-09-21 |
20170266156 | METHOD FOR PREVENTING CANCER BY USING PHTHALIDES | 2017-09-21 |
20170266157 | METHODS FOR WOUND HEALING AND SCAR PREVENTION | 2017-09-21 |
20170266158 | FORMULA COMPRISING A HYPOLIPIDEMIC AGENT | 2017-09-21 |
20170266159 | Enalapril Formulations | 2017-09-21 |
20170266160 | METHODS FOR TREATING PULMONARY EMPHYSEMA USING SUBSTITUTED 2-AZA-BICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID (BENZYL-CYANO-METHYL)-AMIDES INHIBITORS OF CATHEPSIN C | 2017-09-21 |
20170266161 | COMPOUNDS, COMPOSITIONS AND METHODS FOR MAKING THE SAME | 2017-09-21 |
20170266162 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND | 2017-09-21 |
20170266163 | METHODS FOR RESTORATION OF HISTAMINE BALANCE | 2017-09-21 |
20170266164 | NEW METHODS AND USES | 2017-09-21 |
20170266165 | Soft Chewable Pharmaceutical Products | 2017-09-21 |
20170266166 | Compositions and Methods to Inhibit Estrogen Receptor Beta for the Treatment of Renal Cell Carcinoma | 2017-09-21 |
20170266167 | ERK INHIBITORS | 2017-09-21 |
20170266168 | METHODS FOR PREVENTING OR TREATING OSTEOARTHRITIS | 2017-09-21 |
20170266169 | CYP2J2 ANTAGONISTS IN THE TREATMENT OF PAIN | 2017-09-21 |
20170266170 | PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY | 2017-09-21 |